Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...
BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.
The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?
Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary ...
TOKYO, Feb. 3, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projects for ...
There are hundreds of thousands of meteorites hidden beneath Antarctica's icy surface, some of which are slowly sinking out ...
A new study led by Mary Christine Simon at the Institute for Nutrition and Food Science at Bonn University has shown that ...